Seasonal Influenza Vaccines KOL Interviews - Product Image

Seasonal Influenza Vaccines KOL Interviews

  • ID: 4331626
  • Report
  • 22 pages
  • Datamonitor Healthcare
1 of 2
The author interviewed two infectious disease experts, one based in the US and one in France, to gauge their views on the seasonal influenza vaccines market, its outlook over the next five years and any key events that are likely to take place, including the impact of novel quadrivalent inactivated influenza vaccines and other incremental advances.

The vaccines discussed are Fluad, FluBlok, Flucelvax, FluMist Quadrivalent (AZN), Fluzone High Dose (SNY) and Intanza (SNY).

The two interviews were combined into a single report.
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
Note: Product cover images may vary from those shown
Adroll
adroll